Green, Martin

Overview 

Dr. Martin Green is a Cardiologist at the University of Ottawa Heart Institute and Professor in the Department of Medicine at the University of Ottawa. He is the current director of the Postgraduate EP Fellowship program at the Heart Institute.

Background 

Dr. Green graduated from the Faculty of Medicine at the University of Toronto in 1975, at which time he was awarded the KJR Wightman Award in Internal Medicine and the Cody Silver Medal.

He trained in Internal Medicine at the University of Ottawa, receiving his Fellow of the Royal College of Physicians and Surgeons of Canada (FRCPC) in Medicine and in Cardiology in 1981.

He then travelled to Maastricht, the Netherlands, to further his training in Cardiac Electrophysiology under the direction of Professor Hein J. J. Wellens as a Fellow of the Medical Research Council of Canada. There, he obtained a Fellowship in Electrophysiology from the University of Limburg in Maastricht.

Dr. Green returned to Ottawa to start the Arrhythmia Service in 1983. Since that time, the Arrhythmia Service has grown substantially and produced world class clinical arrhythmia care and research.

Research & Clinical Interests 

Dr. Green’s clinical interests include cardiac arrhythmias, cardiac ablation and mapping, implantable devices and electrocardiography. His research interests focus on mechanisms and therapies for cardiac arrhythmias, in particular, anti-arrhythmic drugs and catheter ablation for atrial fibrillation.

Publications 

LATEST PUBLICATIONS

  • Farwell D, Green MS, Lemery R, Gollob M, Birnie D. Accelerating risk of Fidelis lead fracture. Heart Rhythm 2008 Oct;5(10):1375-1379 (Epub 2008 Jul 3).
  • Davis DR, Tang AS, Gollob MH, Lemery R, Green MS, Birnie DH. Remote magnetic navigation-assisted catheter ablation enhances catheter stability and ablation success with lower catheter temperatures. Pacing Clin Electrophysiol 2008 Jul;31(7):893-898.
  • Farwell D, Redpath C, Birnie D, Gollob M, Lemery R, Posan E, Green M. Inappropriate implantable cardioverter defibrillator shocks in fractured Sprint Fidelis leads associated with "appropriate” interrogation. Europace 2008;10(6):726-728.
  • Al-Rawahi N, Green MS. Diagnosis of supraventricular tachycardia. J Assoc Physicians India 2007;4(55): S21-24.
  • Humphries KH, Lee M, Sheldon R, Ramanathan K, Dorian P, Green M, Kerr CR for the CARAF Investigators. Statin use and recurrence of atrial fibrillation following successful cardioversion. Am Heart J 2007;154(5):908-913.

PAPERS IN REFEREED JOURNALS

  • Brugada P, Bar FWHM, de Zwann C, Roy D, Green M, Wellens HJJ. "Sawfish" Systolic Narrowing of the Left Anterior Descending Coronary Artery: An Angiographic Sign of Hypertrophic Cardiomyopathy. Circulation 1982;66(4):800 803.
  • Dassen W, Brugada P, Richards D, Green M, Heddle B, Wellens HJJ. A Mathematical Model of the Conduction System to Study Mechanisms of Cardiac Arrhythmias. Computers in Cardiology, IEEE Silver Springs, Maryland 1982.
  • Wehr M, Brugada P, Green M, Abdollah H, Wellens HJJ. Die Bedeutung Der AV Leitungskurve Fur Die Initiierung Einer AV Knoten Tachykardie. Zeitschrift Fur Kardiologie, April 1983.
  • Green M, Brugada P, Wellens HJJ. Incessant Dual Supraventricular Tachycardia in a Child. PACE 1983;6:624 630.
  • Green M, Heddle B, Dassen W, Wehr, W, Abdollah H, Brugada P, Wellens HJ. The Value of QRS Alternation in Determining the Site of Origin in Narrow QRS Supraventricular Tachycardia. Circulation 1983;68(2):368 373.
  • Wehr M, Brugada P, Green M, Abdollah H, Wellens HJJ. Ventricular Tachycardia with Alternate Ventriculoatrial Wenckebach Conduction Due to Two Level Block. PACE 1984; 7:79.
  • Brugada P, Green M, Abdollah H, Wellens HJJ. Significance of Ventricular Arrhythmias Initiated by Programmed Ventricular Stimulation: The Importance of the Ventricular Arrhythmia Induced and the Number of Premature Stimuli Required. Circulation 1984;69:87 92.
  • Brugada P, Farre J, Green M, Heddle B, Roy D, Wellens HJJ. Observations in Patients with Supraventricular Tachycardia having a P R Interval Shorter than the R P Interval: Differentiation Between Atrial Tachycardia and Reciprocating Atrioventricular Tachycardia Using an Accessory Pathway with Long Conduction Times. Am. Heart J 1984:556 570.
  • Abdollah H, Brugada P, Green M, Wehr M, Wellens HJJ, Paulussen G. Clinical Efficacy and Electrophysiologic Effects of Intravenous and Oral Encainide in Patients with Accessory Atrioventricular Pathways and Supraventricular Arrhythmias. Am. J. of Cardiology 1984;54(6): 544 549.
  • D'Alton JG, Preston DN, Bormanis J, Green MS, Kragg G. Multiple Transient Ischemic Attacks, Lupus Anticoagulant and Verrucous Endocarditis. Stroke 1995;16(3).
  • Davies RA, Koshal A, Jindal S, Green M, Morton B, Chan K, Dafoe W, Runstedler B, Saginur R, Beanlands D, Keon W. University of Ottawa Heart Institute Transplant Program. The Journal of Heart Transplantation 1986;5:57 58.
  • Davies RA, Koshal A, Walley V, Runstedler B, Green M, Morton B, Jindal S, Beanlands D, Keon W. Temporary Diastolic Non Compliance with Preserved Systolic Function after Heart Transplantation. Transplantation Proceedings 1987;9(4).
  • The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Special Report - Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-12.
  • Epstein A, Bigger T, Wyse G, Romhilt D, Reynolds-Haertle R, Hallstrom A & CAST Investigators. Events in the Cardiac Arrhythmia Suppression Trial (CAST): Mortality in the Entire Population Enrolled. JACC 1991;18(1).
  • Wyse G, Hallstrom A, McBride R, Cohen J, Steinberg J, Mahmarian J & CAST Investigators Events in the Cardiac Arrhythmia Suppression Trial (CAST): Mortality in Patients Surviving Open Label Titration But Not Randomized to Double-Blind Therapy. JACC 1991;18(1)
  • Connolly S, Laupacis A, Gent M, Roberts R, Cairns J, Joyner C for the CAFA Study Coinvestigators Canadian Atrial Fibrillation Anticoagulation (CAFA) study. JACC 1991;18(2):349-355.
  • The Cardiac Arrhythmia Suppression Trial (CAST II) Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. NEJM 1992;327:227-233.
  • Strauss B, Green M. Electrocardiographic prediction of ejection fraction and site of LAD occlusion in anterior myocardial infarction. Clin Cardiol 1993;16:213-217.
  • Kantoch MJ, Green MS, Tang ASL. Randomized cross-over evaluation of two adaptive pacing algorithms for the treatment of ventricular tachycardia. PACE 1993;16:1664-1672.
  • Connolly SJ, Gent M, Roberts RS, Dorian P, Green MS, Klein GJ, Mitchell LB, Sheldon RS, Roy D on behalf of the CIDS Co-Investigators. Canadian Implantable Defibrillator Study (CIDS): Study Design and Organization. American Journal of Cardiology 1993; 72:103F-108F.
  • Wolfsohn A, Green M, Walley VM. Pathology of radiofrequency catheter ablation of the atrioventricular node. Modern Pathology 1994;7(4):494-496.
  • Dorian P, Newman D, Tang A, Green M. d-Sotalol decreases defibrillation energy requirements in humans: A prospective controlled study. Pacing and Clinical Electrophysiology 1994; 7(4):828.
  • Al-Saadon K, Walley VM, Green M, Beanlands DS. Angiographic diagnosis of true and false LV aneurysms after inferior wall myocardial infarction. Cath Cardiovasc Diagnosis 1995;35:266-269.
  • Krahn AD, Klein GJ, Kerr CR, Boone J, Sheldon R, Green M, Talajic M, Wang X, Connolly S. Thyroid function in patients with atrial fibrillation. Arch Int Med 1996; 156:2221-2224.
  • C Kerr, Primary Panelists and Secondary Panelists. Green M in group of Secondary Panelists.Canadian Cardiovascular Society Consensus Conference on Atrial Fibrillation. Can J Cardiol 1996; 12(A).
  • Skanes A, Green M. What have clinicals trials taught us about proarrhythmia? Can J of Cardiol 1996;12:20B.
  • Tang ASL, Morton BC, Green MS, Beanlands R. Improvement of ventricular function after atrioventricular junction ablation in a patient with atrial flutter after Mustard's operation. Can J Cardiol 1996;12(5):523-525.
  • Laupacis A, Sullivan K and the Canadial Atrial Fibrillation Anticoagulation Study Group*. Canadian atrial fibrillation anticoagulation study: Were the patients subsequently treated with warfarin? Can Med Assoc J 1996;154 (11):1669-1674.
  • Tang ASL, Hendry P, Goldstein W, Green MS & Luce M. Nonthoracotomy implantation of cardioverter defibrillators: Preliminary experience with a defibrillation lead placed at the right ventricular outflow tract. PACE 1996;19:960-964.
  • Dorian P, Newman D, Sheahan R, Tang A, Green M, Mitchell J. D-sotalol decreases defibrillation energy requirements in humans: A novel indication for drug therapy. J of Cardiovascular Electrophysiology 1996;7(10):952-961.
  • C Kerr, J Boone, S Connolly S, Green M, Klein G, Sheldon R & Talajic M. Follow-up of atrial fibrillation: The initial experience of the Canadian Registry of Atrial Fibrillation. European Heart Journal 1996;17:48-51C.
  • Skanes AC, Green MS, Tang ASL. A case of wide complex tachycardia after ventricular tachycardia surgery. PACE 1997;20(1):356-358.
  • Skanes AC, Morton BC, Green MS, Tang ASL. Torsade de pointes with amidarone in a patient with previous torsade during beta receptor blockade. Can J Cardiol 1997;13(4):383-386.
  • Vora AM, Green MS, Tang ASL. An unusual mechanism of incessant supraventricular tachycardia. PACE 1997;20(I):982-984.
  • Vora A, Green, MS, Tang ASL. Idiopathic Ventricular Tachycardia: What is the Mechanism? PACE 1997;20:2855-2856.
  • Vora AM Green, MS, Tang ASL. Atrioventricular Nodal Reentry Tachycardia with AV Block. J Interventional Cardiac Electrophysiology 1997;1:287-289.
  • Vora, AM., Green, MS, Tang, ASL. Safety and Feasibility of Same Day Discharge in Patients Undergoing Radiofrequency Catheter Ablation. Am. J. Cardiol 1998;81:233-235.
  • Vora A, Green M. Arrhythmia of the Month: Atrial tachycardia in a patient with tricuspid atresia and Fontan surgery. J of Cardiovasc Electrophysiology 1998;9(3);334-335.
  • Khaykin Y, Dorian P, Tang A, Green M, Mitchell J, Wulffhardt Z, Newman D. The effect of sinus node depression on heart rate variability: The effects of zatebradine, a selective bradycardic agent. Can J Physiol. Pharmacol. 1998;76:1-5.
  • Walley VM, Bourke ME, Green M, Stinson WA, Veinot JP. Implantable Cardioverter-defibrillators and the pathologist: Comment and cautionary notes. J of Forensic Sciences 1998;43(5):969-973.
  • Chiamvimonvat V, Newman D, Tang A, Green M, Mitchell J, Wulffhart Z & Dorian P. A Double-blind placebo-controlled evaluation of the human electrophysiologic effects of Zatebradine, a sinus node inhibitor. J of Cardiovascular Pharmacology 1998;32(4):516-520.
  • Kerr CR, Boone J, Connolly SJ, Dorian P, Green M, Klein G, Newman D, Sheldon R, Talajic M. The Canadian Registry of Atrial Fibrillation: A noninterventional follow-up of patients after the first diagnosis of atrial fibrillation. AM J Cardiol 1998;82:82-85N.
  • Connors SP, Vora A, Green MS, Tang ASL Radiofrequency ablation of atrial tachycardia originating from the triangle of Koch. . Can J Cardiol 2000;16(1):39-43.
  • Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O’Brien B for the CIDS Investigators. Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-1302.
  • Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagne P, Nattel S & Thibault B for the Canadian Trial of Atrial Fibrillation Investigators. Amiodarone to prevent recurrence of atrial fibrillation. NEJM 2000;342(13):913-920.
  • Ali F, Tang AS, Green MS. Radiofrequency catheter ablation for ventricular arrhythmias. Indian Heart Journal 2000;52(3):273-279.
  • Green, MS, Ricci J, Wolfe K. The appropriate evaluation of the patient at risk for sudden death from ventricular arrhythmias. CCS 1999 Consensus Conference on Prevention of Sudden Death from Ventricular Arrhythmia, Chapter 2. Can J Cardiol 2000;16:13-15C.
  • Isotalo PA, Green M, Tang A, Lach B, Veinot JP. Metastatic calcification of the cardiac conduction system with heart block: An under-reported entity in chronic renal failure patients. J Forensic Sci 2000;45(6):1335-1338.
  • Birnie D, Tang AS, Green MS, Davies RA, Veinot J. Interatrial conduction of atrial tachycardia in heart transplant recipients: potential pathophysiology. J of Heart & Lung Transplantation 2000;19(10):1007-1010.
  • Birnie D, Green MS, Tang AS. SVT or VT? Diagnostic dilemma in a patient with a dual chamber implantable cardioverter defibrillator. Pacing Clinical Electrophysiology 24(5):889-890, 2001
  • Humphries KH, Kerr CR, Connolly S, Klein G, Boone JA, Green M, Sheldon R, Talajic M, Dorian P, Newman D (CARAF Investigators). New onset atrial fibrillation—Sex differences in presentation, treatment and outcome. Circulation 2001:2365-2370.
  • Gollob MH, Green MS, Tang ASL, Gollob T, Karibe A, Hassan A, Ahmad F, Lozado R, Shah G, Fannanapazir L, Bachinski LL, Roberts R. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. NEJM 2001:344(24):1823-1831.
  • Tang ASL, Roberts RS, Kerr C, Gillis AM, Green MS, Talajic M, Yusuf S, Abdollah H, Grent M, Connolly SJ and the Canadian Trial of Physiologic Pacing (CTOPP) Investigators. Relationship between pacemaker dependency and the effect of pacing mode on cardiovascular outcomes. Circulation 2001:3081-3085.
  • Gollob MH, Green MS, Roberts R. Letter to the Editor: A gene responsible for familial Wolff-Parkinson-White syndrome. NEJM 2001:345(15):1063-1064.
  • Dorian P, Paquette M, Newman D, Green M, Connolly SJ, Talajic M, Roy D for the CTAF Investigators. Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation. Am Heart J 2002:143(6):984-990.
  • Nichol G, McAlister F, Phama B, Laupacis A, Shea B, Green M, Tang ASL, Wells G. Meta-analysis of randomized controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation. Heart 2002; 87(6):535-543.
  • Gollob MH, Green MS, Tang ASL, Roberts R. PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease and cardiac hypertrophy. Current Opinion in Cardiology 2002; 17:229-234.
  • Ali FI, Green MS, Tang AS, Lemery R. A cool ablation. J Cardiovasc Electrophysiol 2002;13(3):299.
  • The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347(23):1825-1833.
  • Stobie P, Green MS. Cryoablation for septal accessory pathways: Has the next ice age arrived? J Cardiovasc Electrophysiol 2003;14(8):830-831.
  • Birnie D, Connors SP, Veinot JP, Green M, Stinson WA, Tang AS. Left atrial vein pacing. Pacing Clin Electrophysiol 2004;27(2):240-245.
  • Lelorier P, Humphries KH, Krahn A, Connolly SJ, Talajic M, Green M, Sheldon R, Dorian P, Newman D, Kerr CR, Yee R, Klein GJ. Prognostic differences between atrial fibrillation and atrial flutter. Am J of Cardiology 2004;93:647-649.
  • Healey JS, Theoret-Patrick P, Green MS, Lemery R, Birnie D, Tang ASL. Reverse atrial electrical remodelling following atrial defibrillation as determined by signal-averaged ECG. Can J of Cardiology 2004;20(3):311-315.
  • Friedman PL, Dubuc M, Green MS, Jackman WM, Keane DTJ, Marinchak RA, Nazari J, Packer DL, Skanes A, Steinberg JS, Stevenson WG, Tchou PJ, Wilber DJ, Worley SJ. Catheter cryoablation of supraventricular tachycardia: Results of the multicenter prospective “Frosty” trial. Heart Rhythm 2004;1(2):129-138.
  • Lau EW, Green MS, Birnie D, Lemery, Tang ASL. Atrial tracking paradox: Is the dual chamber pacemaker working properly? PACE 2004; 27(8):1148-1150.
  • Parkash R, Green M, Kerr CR, Connolly SJ, Klein GJ, Sheldon R, Talajic M, Dorian P, Humphries KH. The association of left atrial size and occurrence of atrial fibrillation. A Prospective cohort study from the Canadian Registry of Atrial Fibrillation. Am Heart J 2004;148(4):649-654.
  • Lemery, R, Soucie, L, Martin B, Tang ASL, Green M, Healey J. Human study of biatrial electrical coupling – Determinants of endocardial septal activation and conduction over interatrial connections. Circulation 2004; 110:2083-2089.
  • Lau EW, Green MS, Birnie DH, Lemery R, Tang A. Preexcitation masking underlying aberrant conduction: An atriofascicular accessory pathway functioning as an ectopic right bundle branch. Heart Rhythm 2004; 4:497-499.
  • Humphries KH, Kerr CR, Steinbuch M, Dorian P, for the Canadian Registry of Atrial Fibrillation (CARAF) Investigators. Limitations to antiarrhythmic drug use in patients with atrial fibrillation. CMAJ 2004; 171:741-745.
  • Lau EW, Green MS, Birnie DS, Lemery R, Tang ASL. EP Rounds: Ventricular tachycardia terminated by an ICD: Is there more than what meets the eye? PACE 2004; 27:1656-1658.
  • Lau EW, Green MS, Gow R, Tang ASL. Paroxysmal supraventricular tachycardia with atrioventricular block: What is the mechanism? Heart Rhythm 2005; 2(2):207-209.
  • Lau E, Green M, Birnie D, Lemery R, Tang A. Letter to the Editor Response. Heart Rhythm 2005; 2(2):221.
  • Lau EW, Birnie DH, Lemery R, Tang AS, Green MS. Acupuncture triggering inappropriate ICD shocks. Europace 2005; 7(1):85-86.
  • Kerr C, Humphries K, Talajic M, Klein G, Connolly S, Green M, Boone J, Sheldon R, Dorian P, Newman D. Progression to chronic atrial fibrillation following the initial diagnosis of paroxysmal atrial fibrillation: Results from the Canadian Registry of Atrial Fibrillation (CARAF). Am Heart J 2005; 149(3):489-496.
  • Davis D, Krahn A, Tang A, Lemery R, Green M, Gollob M, Yee R, Skanes A, Klein G, Birnie D. Long-term outcome of cardiac resynchronization therapy in patients with severe congestive heart failure. Can J Cardiol 2005; 21(5):413-417.
  • Olshansky B, Heller EN, Mitchell LB, Chandler M, Slater W, Green M, Brodsky M, Barrell P, Greene HL & the AFFIRM Investigators. Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke? Results from the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study. JACC 2005; 45(12):2026-2033.
  • Green, MS. Editorial Comment – The “vices” in devices. Current Opinion in Cardiology 2006; 21:77.
  • Simpson CS, Healey JS, Philippon F, Dorian P, Mitchell, LB, Sapp Jr, JL, O’Neill BJ, Sholdice MM, Green MS, Sterns LD, Yee R for the Can Cardiovasc Society Access to Care Working Group and the Can Heart Rhythm Society. Universal access–but when? Treating the right patient at the right time: Access to electrophysiology services in Canada. Can J Cardiol 2006; 22(9):741-746.
  • Gollob MH, Green MS, Veinot JP. Altered AMP-activated protein kinase activity and pathologic cardiac disease. Heart and Metabolism 2006; 32:28-31.
  • The ACTIVE Writing Group on behalf of the ACTIVE Investigators. Clopidrogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidrogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomized controlled trial. Lancet 2006; 367:1903-1912.
  • Mielniczuk LM, Williams K, Davis DR, Tang ASL, Lemery R, Green MS, Gollob MH, Haddad H, Birnie DH. Frequency of peripartum cardiomyopathy. J Am Cardiol 2006: 97:1765-1768.
  • Davis DR, Gollob MH, Green MS, Lemery R, Tang AS, Birnie. Appropriate result from an inappropriate ICD shock. PACE 2006; 29:1183-1184.
  • Davis DR, Lemery R, Green M, Gollob MH, Tang AS, Birnie DH. Transient left ventricular apical ballooning following a prolonged ablation. J Interv Card Electrophysiol 2006: Oct 17(1):47-49.
  • Davis DR, Tang AS, Lemery R, Green MS, Gollob MH, Birnie DH. Influence of gender on ICD implantation for primary and secondary prevention of sudden cardiac death. Europace 2006; Dec 8(12):1054-1056.
  • Green M, Gollob M. Comment on “Familial pseudo Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol 2006 Dec;17(12):E9.
  • Davis DR, Lemery R, Green M, Gollob MH, Tang ASL. Transient left ventricular apical ballooning following a prolonged ablation. J Interv Card Electrophysiol 2006; 17:47-49 (published online January 17, 2007).
  • Lemery R, Birnie, Tang AS, Green M, Gollob M, Hendry M, Lau E. Normal atrial activation and voltage during sinus rhythm in the human heart: an endocardial and epicardial mapping study in patients with a history of atrial fibrillation J Cardiovasc Electrophysiol 2007 Apr; 18(4):402-8.
  • Birnie DH, Sambell C, Johansen H, Williams K, Lemery R, Green MS, Gollob MH, Lee DS, Tang ASL. Use of implantable cardioverter defibrillators in Canadian and US survivors of out-of-hospital cardiac arrest. CMAJ 2007; 177(1):41-46.
  • Rutberg J, Green MS, Gow RM, Geraghty MT, Honeywell C, Ewen J, Birnie DH, Tang A, Lemery R, Gollob MH. Molecular autopsy in the sudden cardiac death of a young woman: A first Canadian report. Can J Cardiol 2007; 23(11):904-906.
  • Humphries KH, Lee M, Sheldon R, Ramanathan K, Dorian P, Green M, Kerr CR for the CARAF Investigators. Statin use and recurrence of atrial fibrillation following successful cardioversion. Am Heart J 2007;154(5):908-913.
  • Al-Rawahi N, Green MS. Diagnosis of supraventricular tachycardia. J Assoc Physicians India 2007;4(55): S21-24.
  • Farwell D, Redpath C, Birnie D, Gollob M, Lemery R, Posan E, Green M. Inappropriate implantable cardioverter defibrillator shocks in fractured Sprint Fidelis leads associated with "appropriate” interrogation. Europace 2008;10(6):726-728.
  • Davis DR, Tang AS, Gollob MH, Lemery R, Green MS, Birnie DH. Remote magnetic navigation-assisted catheter ablation enhances catheter stability and ablation success with lower catheter temperatures. Pacing Clin Electrophysiol 2008 Jul;31(7):893-898.
  • Farwell D, Green MS, Lemery R, Gollob M, Birnie D. Accelerating risk of Fidelis lead fracture. Heart Rhythm 2008 Oct;5(10):1375-1379 (Epub 2008 Jul 3).

Share This